Puriblood Medical Co., Ltd. (TPEX:6847)
74.80
-0.10 (-0.13%)
Sep 8, 2026, 1:04 PM CST
Puriblood Medical Revenue
Puriblood Medical had revenue of 38.46M TWD in the half year ending June 30, 2026, with 14.54% growth. This brings the company's revenue in the last twelve months to 80.54M, down -31.36% year-over-year. In the year 2025, Puriblood Medical had annual revenue of 82.34M, down -25.61%.
Revenue (ttm)
80.54M
Revenue Growth
-31.36%
P/S Ratio
12.84
Revenue / Employee
n/a
Employees
38
Market Cap
1.03B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 82.34M | -28.34M | -25.61% |
| Dec 31, 2024 | 110.67M | -14.60M | -11.65% |
| Dec 31, 2023 | 125.27M | -12.17M | -8.86% |
| Dec 31, 2022 | 137.44M | 82.86M | 151.79% |
| Dec 31, 2021 | 54.59M | 15.94M | 41.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| BIONET | 1.29B |
| DIVA Laboratories | 894.67M |
| Genetics Generation Advancement | 614.42M |
| Kim Forest Enterprise | 599.63M |
| Welgene Biotech | 398.92M |
| Sofiva Genomics | 379.21M |
| Pharmigene | 187.88M |